According to the latest report by IMARC Group, titled “United States DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the united states DNA sequencing products market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2027, exhibiting a growth rate (CAGR) of 16.2% during 2022-2027.

Deoxyribonucleic acid (DNA) sequencing products are medical instruments used to ascertain the nucleotide sequence of the DNA. They assist healthcare professionals in gaining insights into the genetic function of living organisms and enhancing the metagenomic identification of closely related species to separate plasmids from the genome. Presently, they are extensively utilized across the United States to facilitate precise diagnosing and provide effective and personalized treatment plans for fatal ailments like cancer.

Request for a free sample copy of this report: https://www.imarcgroup.com/united-states-dna-sequencing-products-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

Significant growth in the field of bioinformatics for identifying genes, establishing their functions, and developing gene-based strategies for diagnosing, preventing, and treating diseases represent one of the major factors primarily driving the market in the US. Additionally, key players in the country are launching advanced data analysis toolkits and a new suite of workflow functionality for detecting and identifying SARS-CoV-2 (COVID-19) viral sequences. Apart from this, increasing investments by public and private firms in the country to conduct extensive research and development (R&D) activities for introducing advanced DNA sequencing products are anticipated to propel market growth.

Breakup by Product Type:

  • Consumables and Reagents
  • Equipments

Breakup by Application:

  • Biomarkers
  • Diagnostics
  • Reproductive Health
  • Forensics
  • Personalized Medicine
  • Others

Breakup by End User:

  • Academic and Government Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Others

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape:

The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/united-states-dna-sequencing-products-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800